nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.294	1	CiPCiCtD
Budesonide—Prednisone—prostate cancer	0.202	1	CrCtD
Budesonide—NR3C1—prostate cancer	0.0886	0.633	CbGaD
Budesonide—CYP3A4—prostate cancer	0.0514	0.367	CbGaD
Budesonide—Testolactone—Estrone—prostate cancer	0.0235	0.153	CrCrCtD
Budesonide—NR3C1—Prednisone—prostate cancer	0.023	0.187	CbGbCtD
Budesonide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0207	0.168	CbGbCtD
Budesonide—CYP3A4—Bicalutamide—prostate cancer	0.0109	0.0883	CbGbCtD
Budesonide—CYP3A4—Estramustine—prostate cancer	0.0101	0.0821	CbGbCtD
Budesonide—CYP3A4—Abiraterone—prostate cancer	0.009	0.0731	CbGbCtD
Budesonide—CYP3A4—Flutamide—prostate cancer	0.009	0.0731	CbGbCtD
Budesonide—Ciclesonide—Prednisone—prostate cancer	0.00775	0.0505	CrCrCtD
Budesonide—CYP3A4—Cabazitaxel—prostate cancer	0.00666	0.0541	CbGbCtD
Budesonide—CYP3A4—Estrone—prostate cancer	0.00651	0.0529	CbGbCtD
Budesonide—Hydrocortamate—Prednisone—prostate cancer	0.00648	0.0422	CrCrCtD
Budesonide—Testolactone—Prednisone—prostate cancer	0.00609	0.0397	CrCrCtD
Budesonide—Prednicarbate—Prednisone—prostate cancer	0.00609	0.0397	CrCrCtD
Budesonide—Fluocortolone—Prednisone—prostate cancer	0.00592	0.0386	CrCrCtD
Budesonide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0058	0.0471	CbGbCtD
Budesonide—Alclometasone—Prednisone—prostate cancer	0.00576	0.0375	CrCrCtD
Budesonide—Amcinonide—Prednisone—prostate cancer	0.0056	0.0365	CrCrCtD
Budesonide—Clobetasol propionate—Prednisone—prostate cancer	0.00546	0.0356	CrCrCtD
Budesonide—Diflorasone—Prednisone—prostate cancer	0.00546	0.0356	CrCrCtD
Budesonide—Desonide—Prednisone—prostate cancer	0.00546	0.0356	CrCrCtD
Budesonide—Flunisolide—Prednisone—prostate cancer	0.00546	0.0356	CrCrCtD
Budesonide—Paramethasone—Prednisone—prostate cancer	0.00532	0.0347	CrCrCtD
Budesonide—Desoximetasone—Prednisone—prostate cancer	0.00519	0.0338	CrCrCtD
Budesonide—Loteprednol—Prednisone—prostate cancer	0.00507	0.033	CrCrCtD
Budesonide—Fluorometholone—Prednisone—prostate cancer	0.00507	0.033	CrCrCtD
Budesonide—Triamcinolone—Prednisone—prostate cancer	0.00507	0.033	CrCrCtD
Budesonide—Mometasone—Prednisone—prostate cancer	0.00507	0.033	CrCrCtD
Budesonide—Fluprednidene Acetate—Prednisone—prostate cancer	0.00507	0.033	CrCrCtD
Budesonide—Dexamethasone—Prednisone—prostate cancer	0.00495	0.0323	CrCrCtD
Budesonide—Rimexolone—Prednisone—prostate cancer	0.00495	0.0323	CrCrCtD
Budesonide—Betamethasone—Prednisone—prostate cancer	0.00495	0.0323	CrCrCtD
Budesonide—Methylprednisolone—Prednisone—prostate cancer	0.00474	0.0309	CrCrCtD
Budesonide—Prednisolone—Prednisone—prostate cancer	0.00464	0.0302	CrCrCtD
Budesonide—Hydrocortisone—Prednisone—prostate cancer	0.00445	0.029	CrCrCtD
Budesonide—CYP3A4—Conjugated Estrogens—prostate cancer	0.00426	0.0346	CbGbCtD
Budesonide—CYP3A4—Mitoxantrone—prostate cancer	0.00387	0.0314	CbGbCtD
Budesonide—CYP3A4—Estradiol—prostate cancer	0.00374	0.0304	CbGbCtD
Budesonide—CYP3A4—Prednisone—prostate cancer	0.00321	0.0261	CbGbCtD
Budesonide—CYP3A4—Etoposide—prostate cancer	0.00244	0.0198	CbGbCtD
Budesonide—CYP3A4—Docetaxel—prostate cancer	0.00223	0.0181	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—prostate cancer	0.00166	0.0135	CbGbCtD
Budesonide—NR3C1—urine—prostate cancer	0.000466	0.262	CbGeAlD
Budesonide—CYP3A4—urine—prostate cancer	0.000352	0.198	CbGeAlD
Budesonide—NR3C1—prostate gland—prostate cancer	0.000167	0.0942	CbGeAlD
Budesonide—Amcinonide—ANXA1—prostate cancer	0.000148	0.0848	CrCbGaD
Budesonide—NR3C1—seminal vesicle—prostate cancer	0.000141	0.0797	CbGeAlD
Budesonide—NR3C1—epithelium—prostate cancer	0.000123	0.0692	CbGeAlD
Budesonide—NR3C1—renal system—prostate cancer	0.000114	0.0642	CbGeAlD
Budesonide—NR3C1—urethra—prostate cancer	0.000112	0.0631	CbGeAlD
Budesonide—CYP3A4—renal system—prostate cancer	8.62e-05	0.0486	CbGeAlD
Budesonide—NR3C1—bone marrow—prostate cancer	8.62e-05	0.0486	CbGeAlD
Budesonide—NR3C1—testis—prostate cancer	7.37e-05	0.0415	CbGeAlD
Budesonide—Hydrocortisone—ANXA1—prostate cancer	6.23e-05	0.0357	CrCbGaD
Budesonide—Testolactone—CYP19A1—prostate cancer	5.94e-05	0.0341	CrCbGaD
Budesonide—Dexamethasone—CYP3A43—prostate cancer	5.87e-05	0.0337	CrCbGaD
Budesonide—NR3C1—lymph node—prostate cancer	5.34e-05	0.0301	CbGeAlD
Budesonide—Clocortolone—NR3C1—prostate cancer	4.81e-05	0.0276	CrCbGaD
Budesonide—Prednicarbate—NR3C1—prostate cancer	4.81e-05	0.0276	CrCbGaD
Budesonide—Dexamethasone—ANXA1—prostate cancer	4.64e-05	0.0266	CrCbGaD
Budesonide—Diflorasone—NR3C1—prostate cancer	4.56e-05	0.0261	CrCbGaD
Budesonide—Desonide—NR3C1—prostate cancer	4.56e-05	0.0261	CrCbGaD
Budesonide—Desoximetasone—NR3C1—prostate cancer	4.44e-05	0.0255	CrCbGaD
Budesonide—Loteprednol—NR3C1—prostate cancer	4.39e-05	0.0252	CrCbGaD
Budesonide—Beclomethasone—CYP3A5—prostate cancer	4.15e-05	0.0238	CrCbGaD
Budesonide—Flurandrenolide—NR3C1—prostate cancer	3.89e-05	0.0223	CrCbGaD
Budesonide—Hydrocortamate—NR3C1—prostate cancer	3.76e-05	0.0216	CrCbGaD
Budesonide—Amcinonide—NR3C1—prostate cancer	3.5e-05	0.0201	CrCbGaD
Budesonide—Mometasone—NR3C1—prostate cancer	3.33e-05	0.0191	CrCbGaD
Budesonide—Rimexolone—NR3C1—prostate cancer	3.29e-05	0.0189	CrCbGaD
Budesonide—Fluocinonide—NR3C1—prostate cancer	3.1e-05	0.0178	CrCbGaD
Budesonide—Beclomethasone—NR3C1—prostate cancer	3.1e-05	0.0178	CrCbGaD
Budesonide—Fluocinolone Acetonide—NR3C1—prostate cancer	3.01e-05	0.0173	CrCbGaD
Budesonide—Alclometasone—NR3C1—prostate cancer	3.01e-05	0.0173	CrCbGaD
Budesonide—Clobetasol propionate—NR3C1—prostate cancer	2.94e-05	0.0168	CrCbGaD
Budesonide—Flunisolide—NR3C1—prostate cancer	2.94e-05	0.0168	CrCbGaD
Budesonide—Paramethasone—NR3C1—prostate cancer	2.9e-05	0.0166	CrCbGaD
Budesonide—Ciclesonide—NR3C1—prostate cancer	2.85e-05	0.0164	CrCbGaD
Budesonide—Fluorometholone—NR3C1—prostate cancer	2.83e-05	0.0162	CrCbGaD
Budesonide—Methylprednisolone—NR3C1—prostate cancer	2.73e-05	0.0157	CrCbGaD
Budesonide—Clobetasol propionate—CYP1A1—prostate cancer	2.67e-05	0.0153	CrCbGaD
Budesonide—Dexamethasone—CYP17A1—prostate cancer	2.67e-05	0.0153	CrCbGaD
Budesonide—Prednisolone—CYP2A6—prostate cancer	2.5e-05	0.0143	CrCbGaD
Budesonide—Hydrocortisone—SHBG—prostate cancer	2.48e-05	0.0142	CrCbGaD
Budesonide—Betamethasone—CYP19A1—prostate cancer	2.33e-05	0.0134	CrCbGaD
Budesonide—Triamcinolone—NR3C1—prostate cancer	2.31e-05	0.0132	CrCbGaD
Budesonide—Hydrocortamate—CYP3A4—prostate cancer	2.18e-05	0.0125	CrCbGaD
Budesonide—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	2.12e-05	0.00119	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	2.11e-05	0.00119	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	2.11e-05	0.00118	CbGpPWpGaD
Budesonide—Prednisone—NR3C1—prostate cancer	2.09e-05	0.012	CrCbGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	2.09e-05	0.00118	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	2.06e-05	0.00116	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	2.06e-05	0.00116	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IRS1—prostate cancer	2.05e-05	0.00115	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	2.04e-05	0.00115	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	2.04e-05	0.00115	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NFIC—prostate cancer	2.03e-05	0.00114	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	2.03e-05	0.00114	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	2.01e-05	0.00113	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	2.01e-05	0.00113	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	2.01e-05	0.00113	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	1.99e-05	0.00112	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	1.99e-05	0.00112	CbGpPWpGaD
Budesonide—Hydrocortisone—CYP3A5—prostate cancer	1.97e-05	0.0113	CrCbGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	1.97e-05	0.00111	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—INS—prostate cancer	1.96e-05	0.0011	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	1.94e-05	0.00109	CbGpPWpGaD
Budesonide—Prednisolone—NR3C1—prostate cancer	1.93e-05	0.0111	CrCbGaD
Budesonide—NR3C1—Gene Expression—RPN2—prostate cancer	1.91e-05	0.00107	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	1.91e-05	0.00107	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	1.91e-05	0.00107	CbGpPWpGaD
Budesonide—Prednisone—CYP2C19—prostate cancer	1.91e-05	0.0109	CrCbGaD
Budesonide—NR3C1—Adipogenesis—IGF1—prostate cancer	1.89e-05	0.00107	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	1.89e-05	0.00106	CbGpPWpGaD
Budesonide—Betamethasone—NR3C1—prostate cancer	1.89e-05	0.0108	CrCbGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	1.88e-05	0.00106	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	1.87e-05	0.00105	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	1.86e-05	0.00105	CbGpPWpGaD
Budesonide—Dexamethasone—CYP1B1—prostate cancer	1.85e-05	0.0106	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	1.84e-05	0.00103	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	1.83e-05	0.00103	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	1.82e-05	0.00102	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—QARS—prostate cancer	1.81e-05	0.00102	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	1.81e-05	0.00102	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SERPINE1—prostate cancer	1.8e-05	0.00101	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	1.79e-05	0.00101	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTA3—prostate cancer	1.76e-05	0.000988	CbGpPWpGaD
Budesonide—Alclometasone—CYP3A4—prostate cancer	1.75e-05	0.01	CrCbGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	1.74e-05	0.000977	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	1.73e-05	0.000974	CbGpPWpGaD
Budesonide—Flunisolide—CYP3A4—prostate cancer	1.7e-05	0.00977	CrCbGaD
Budesonide—Paramethasone—CYP3A4—prostate cancer	1.68e-05	0.00964	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	1.66e-05	0.000935	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	1.66e-05	0.000933	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	1.66e-05	0.000932	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TBX5—prostate cancer	1.66e-05	0.000932	CbGpPWpGaD
Budesonide—Ciclesonide—CYP3A4—prostate cancer	1.65e-05	0.00949	CrCbGaD
Budesonide—Fluorometholone—CYP3A4—prostate cancer	1.64e-05	0.00941	CrCbGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	1.63e-05	0.000918	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	1.62e-05	0.000913	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTA4—prostate cancer	1.61e-05	0.000903	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	1.61e-05	0.000903	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	1.6e-05	0.000901	CbGpPWpGaD
Budesonide—Methylprednisolone—CYP3A4—prostate cancer	1.59e-05	0.0091	CrCbGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	1.58e-05	0.000891	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	1.58e-05	0.000886	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTA2—prostate cancer	1.56e-05	0.00088	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	1.55e-05	0.00087	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF3H—prostate cancer	1.54e-05	0.000866	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	1.53e-05	0.000863	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	1.52e-05	0.000858	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTA1—prostate cancer	1.51e-05	0.000849	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—NAT2—prostate cancer	1.49e-05	0.00084	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTO1—prostate cancer	1.49e-05	0.00084	CbGpPWpGaD
Budesonide—Hydrocortisone—NR3C1—prostate cancer	1.47e-05	0.00846	CrCbGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	1.47e-05	0.000828	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	1.47e-05	0.000828	CbGpPWpGaD
Budesonide—Dexamethasone—CYP3A5—prostate cancer	1.47e-05	0.00844	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	1.44e-05	0.000811	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	1.43e-05	0.000805	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2A6—prostate cancer	1.42e-05	0.00817	CrCbGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	1.41e-05	0.000794	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.41e-05	0.000791	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.4e-05	0.00079	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.39e-05	0.000783	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.37e-05	0.000773	CbGpPWpGaD
Budesonide—Dexamethasone—CYP19A1—prostate cancer	1.36e-05	0.00778	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.35e-05	0.000761	CbGpPWpGaD
Budesonide—Triamcinolone—CYP3A4—prostate cancer	1.34e-05	0.00767	CrCbGaD
Budesonide—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	1.33e-05	0.000749	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.32e-05	0.000741	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.32e-05	0.000741	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	1.32e-05	0.00074	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	1.31e-05	0.000738	CbGpPWpGaD
Budesonide—Triamcinolone—PTGS2—prostate cancer	1.31e-05	0.00751	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.26e-05	0.000709	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MBD2—prostate cancer	1.25e-05	0.000706	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TET2—prostate cancer	1.25e-05	0.000706	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	1.25e-05	0.000704	CbGpPWpGaD
Budesonide—Anorexia—Capecitabine—prostate cancer	1.25e-05	0.000188	CcSEcCtD
Budesonide—Nausea—Estradiol—prostate cancer	1.24e-05	0.000188	CcSEcCtD
Budesonide—Vomiting—Mitoxantrone—prostate cancer	1.24e-05	0.000187	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—prostate cancer	1.24e-05	0.000187	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	1.24e-05	0.000697	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.24e-05	0.000696	CbGpPWpGaD
Budesonide—Visual impairment—Epirubicin—prostate cancer	1.23e-05	0.000186	CcSEcCtD
Budesonide—Hypertension—Prednisone—prostate cancer	1.23e-05	0.000186	CcSEcCtD
Budesonide—Rash—Mitoxantrone—prostate cancer	1.23e-05	0.000186	CcSEcCtD
Budesonide—NR3C1—Gene Expression—RPL12—prostate cancer	1.23e-05	0.000692	CbGpPWpGaD
Budesonide—Dermatitis—Mitoxantrone—prostate cancer	1.23e-05	0.000185	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.23e-05	0.000185	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—STAT3—prostate cancer	1.23e-05	0.000689	CbGpPWpGaD
Budesonide—Headache—Mitoxantrone—prostate cancer	1.22e-05	0.000184	CcSEcCtD
Budesonide—Insomnia—Docetaxel—prostate cancer	1.22e-05	0.000184	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.22e-05	0.000684	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.21e-05	0.000683	CbGpPWpGaD
Budesonide—Arthralgia—Prednisone—prostate cancer	1.21e-05	0.000183	CcSEcCtD
Budesonide—Myalgia—Prednisone—prostate cancer	1.21e-05	0.000183	CcSEcCtD
Budesonide—Prednisone—CYP3A4—prostate cancer	1.21e-05	0.00696	CrCbGaD
Budesonide—Paraesthesia—Docetaxel—prostate cancer	1.21e-05	0.000183	CcSEcCtD
Budesonide—Anxiety—Prednisone—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.21e-05	0.000182	CcSEcCtD
Budesonide—Dyspnoea—Docetaxel—prostate cancer	1.2e-05	0.000181	CcSEcCtD
Budesonide—Somnolence—Docetaxel—prostate cancer	1.2e-05	0.000181	CcSEcCtD
Budesonide—Discomfort—Prednisone—prostate cancer	1.2e-05	0.000181	CcSEcCtD
Budesonide—Eye disorder—Epirubicin—prostate cancer	1.2e-05	0.000181	CcSEcCtD
Budesonide—Hypersensitivity—Etoposide—prostate cancer	1.2e-05	0.00018	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—HPGDS—prostate cancer	1.19e-05	0.000671	CbGpPWpGaD
Budesonide—Haemoglobin—Doxorubicin—prostate cancer	1.19e-05	0.00018	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Budesonide—Flushing—Epirubicin—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Budesonide—Cardiac disorder—Epirubicin—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Budesonide—Dyspepsia—Docetaxel—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	1.19e-05	0.000667	CbGpPWpGaD
Budesonide—Haemorrhage—Doxorubicin—prostate cancer	1.19e-05	0.000179	CcSEcCtD
Budesonide—Insomnia—Capecitabine—prostate cancer	1.18e-05	0.000178	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—prostate cancer	1.18e-05	0.000177	CcSEcCtD
Budesonide—Paraesthesia—Capecitabine—prostate cancer	1.17e-05	0.000177	CcSEcCtD
Budesonide—Decreased appetite—Docetaxel—prostate cancer	1.17e-05	0.000177	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—prostate cancer	1.17e-05	0.000177	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	1.17e-05	0.000658	CbGpPWpGaD
Budesonide—Oedema peripheral—Doxorubicin—prostate cancer	1.17e-05	0.000176	CcSEcCtD
Budesonide—Gastrointestinal disorder—Docetaxel—prostate cancer	1.17e-05	0.000176	CcSEcCtD
Budesonide—Asthenia—Etoposide—prostate cancer	1.17e-05	0.000176	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—prostate cancer	1.17e-05	0.000176	CcSEcCtD
Budesonide—Dyspnoea—Capecitabine—prostate cancer	1.16e-05	0.000176	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.16e-05	0.000655	CbGpPWpGaD
Budesonide—Anaphylactic shock—Prednisone—prostate cancer	1.16e-05	0.000175	CcSEcCtD
Budesonide—Fatigue—Docetaxel—prostate cancer	1.16e-05	0.000175	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—prostate cancer	1.16e-05	0.000175	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—prostate cancer	1.16e-05	0.000175	CcSEcCtD
Budesonide—Nausea—Mitoxantrone—prostate cancer	1.16e-05	0.000175	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTT1—prostate cancer	1.16e-05	0.000651	CbGpPWpGaD
Budesonide—Immune system disorder—Epirubicin—prostate cancer	1.16e-05	0.000174	CcSEcCtD
Budesonide—Infection—Prednisone—prostate cancer	1.16e-05	0.000174	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.16e-05	0.00065	CbGpPWpGaD
Budesonide—Mediastinal disorder—Epirubicin—prostate cancer	1.15e-05	0.000174	CcSEcCtD
Budesonide—Constipation—Docetaxel—prostate cancer	1.15e-05	0.000174	CcSEcCtD
Budesonide—Pain—Docetaxel—prostate cancer	1.15e-05	0.000174	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.15e-05	0.000649	CbGpPWpGaD
Budesonide—Dyspepsia—Capecitabine—prostate cancer	1.15e-05	0.000173	CcSEcCtD
Budesonide—Pruritus—Etoposide—prostate cancer	1.15e-05	0.000173	CcSEcCtD
Budesonide—Shock—Prednisone—prostate cancer	1.15e-05	0.000173	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	1.14e-05	0.000644	CbGpPWpGaD
Budesonide—Visual impairment—Doxorubicin—prostate cancer	1.14e-05	0.000172	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.14e-05	0.000642	CbGpPWpGaD
Budesonide—Nervous system disorder—Prednisone—prostate cancer	1.14e-05	0.000172	CcSEcCtD
Budesonide—Tachycardia—Prednisone—prostate cancer	1.14e-05	0.000171	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.14e-05	0.000639	CbGpPWpGaD
Budesonide—Decreased appetite—Capecitabine—prostate cancer	1.14e-05	0.000171	CcSEcCtD
Budesonide—Alopecia—Epirubicin—prostate cancer	1.13e-05	0.000171	CcSEcCtD
Budesonide—Skin disorder—Prednisone—prostate cancer	1.13e-05	0.00017	CcSEcCtD
Budesonide—NR3C1—Gene Expression—EIF3A—prostate cancer	1.13e-05	0.000636	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.13e-05	0.000635	CbGpPWpGaD
Budesonide—Gastrointestinal disorder—Capecitabine—prostate cancer	1.13e-05	0.00017	CcSEcCtD
Budesonide—Fatigue—Capecitabine—prostate cancer	1.13e-05	0.00017	CcSEcCtD
Budesonide—Hyperhidrosis—Prednisone—prostate cancer	1.13e-05	0.00017	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—prostate cancer	1.12e-05	0.000169	CcSEcCtD
Budesonide—Prednisolone—CYP3A4—prostate cancer	1.12e-05	0.00641	CrCbGaD
Budesonide—Pain—Capecitabine—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Budesonide—Constipation—Capecitabine—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—prostate cancer	1.12e-05	0.000168	CcSEcCtD
Budesonide—Feeling abnormal—Docetaxel—prostate cancer	1.11e-05	0.000168	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—prostate cancer	1.11e-05	0.000168	CcSEcCtD
Budesonide—Anorexia—Prednisone—prostate cancer	1.11e-05	0.000167	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—prostate cancer	1.11e-05	0.000167	CcSEcCtD
Budesonide—Gastrointestinal pain—Docetaxel—prostate cancer	1.1e-05	0.000166	CcSEcCtD
Budesonide—Flushing—Doxorubicin—prostate cancer	1.1e-05	0.000166	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—prostate cancer	1.1e-05	0.000166	CcSEcCtD
Budesonide—Flatulence—Epirubicin—prostate cancer	1.1e-05	0.000166	CcSEcCtD
Budesonide—Dexamethasone—NR3C1—prostate cancer	1.1e-05	0.00631	CrCbGaD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	1.1e-05	0.000618	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	1.1e-05	0.000616	CbGpPWpGaD
Budesonide—Betamethasone—CYP3A4—prostate cancer	1.09e-05	0.00628	CrCbGaD
Budesonide—Tension—Epirubicin—prostate cancer	1.09e-05	0.000165	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—prostate cancer	1.09e-05	0.000165	CcSEcCtD
Budesonide—Nervousness—Epirubicin—prostate cancer	1.08e-05	0.000163	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	1.08e-05	0.000608	CbGpPWpGaD
Budesonide—Back pain—Epirubicin—prostate cancer	1.08e-05	0.000163	CcSEcCtD
Budesonide—Feeling abnormal—Capecitabine—prostate cancer	1.08e-05	0.000162	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—prostate cancer	1.08e-05	0.000162	CcSEcCtD
Budesonide—Dizziness—Etoposide—prostate cancer	1.07e-05	0.000162	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—prostate cancer	1.07e-05	0.000162	CcSEcCtD
Budesonide—Betamethasone—PTGS2—prostate cancer	1.07e-05	0.00615	CrCbGaD
Budesonide—Immune system disorder—Doxorubicin—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.07e-05	0.000602	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Capecitabine—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Budesonide—Abdominal pain—Docetaxel—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Budesonide—Body temperature increased—Docetaxel—prostate cancer	1.07e-05	0.000161	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Prednisone—prostate cancer	1.06e-05	0.00016	CcSEcCtD
Budesonide—Insomnia—Prednisone—prostate cancer	1.05e-05	0.000159	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—prostate cancer	1.05e-05	0.000158	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—prostate cancer	1.05e-05	0.000158	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.05e-05	0.000589	CbGpPWpGaD
Budesonide—Paraesthesia—Prednisone—prostate cancer	1.05e-05	0.000158	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—NCOA2—prostate cancer	1.04e-05	0.000587	CbGpPWpGaD
Budesonide—Mental disorder—Doxorubicin—prostate cancer	1.04e-05	0.000157	CcSEcCtD
Budesonide—Urticaria—Capecitabine—prostate cancer	1.04e-05	0.000156	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—prostate cancer	1.03e-05	0.000156	CcSEcCtD
Budesonide—Abdominal pain—Capecitabine—prostate cancer	1.03e-05	0.000156	CcSEcCtD
Budesonide—Body temperature increased—Capecitabine—prostate cancer	1.03e-05	0.000156	CcSEcCtD
Budesonide—Vomiting—Etoposide—prostate cancer	1.03e-05	0.000156	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—prostate cancer	1.03e-05	0.000156	CcSEcCtD
Budesonide—Anaemia—Epirubicin—prostate cancer	1.03e-05	0.000155	CcSEcCtD
Budesonide—Agitation—Epirubicin—prostate cancer	1.03e-05	0.000155	CcSEcCtD
Budesonide—Dyspepsia—Prednisone—prostate cancer	1.02e-05	0.000154	CcSEcCtD
Budesonide—Rash—Etoposide—prostate cancer	1.02e-05	0.000154	CcSEcCtD
Budesonide—Dermatitis—Etoposide—prostate cancer	1.02e-05	0.000154	CcSEcCtD
Budesonide—Headache—Etoposide—prostate cancer	1.02e-05	0.000153	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—prostate cancer	1.02e-05	0.000153	CcSEcCtD
Budesonide—Tension—Doxorubicin—prostate cancer	1.01e-05	0.000153	CcSEcCtD
Budesonide—Decreased appetite—Prednisone—prostate cancer	1.01e-05	0.000153	CcSEcCtD
Budesonide—Dexamethasone—CYP2E1—prostate cancer	1.01e-05	0.0058	CrCbGaD
Budesonide—Dysgeusia—Doxorubicin—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Budesonide—Malaise—Epirubicin—prostate cancer	1.01e-05	0.000152	CcSEcCtD
Budesonide—Fatigue—Prednisone—prostate cancer	1e-05	0.000151	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—prostate cancer	1e-05	0.000151	CcSEcCtD
Budesonide—Vertigo—Epirubicin—prostate cancer	1e-05	0.000151	CcSEcCtD
Budesonide—Dexamethasone—CYP2C19—prostate cancer	1e-05	0.00575	CrCbGaD
Budesonide—Syncope—Epirubicin—prostate cancer	1e-05	0.000151	CcSEcCtD
Budesonide—Back pain—Doxorubicin—prostate cancer	9.98e-06	0.000151	CcSEcCtD
Budesonide—Dexamethasone—CYP1A1—prostate cancer	9.98e-06	0.00573	CrCbGaD
Budesonide—Constipation—Prednisone—prostate cancer	9.95e-06	0.00015	CcSEcCtD
Budesonide—Hypersensitivity—Docetaxel—prostate cancer	9.94e-06	0.00015	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—prostate cancer	9.92e-06	0.00015	CcSEcCtD
Budesonide—Palpitations—Epirubicin—prostate cancer	9.86e-06	0.000149	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—prostate cancer	9.8e-06	0.000148	CcSEcCtD
Budesonide—Cough—Epirubicin—prostate cancer	9.73e-06	0.000147	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	9.73e-06	0.000547	CbGpPWpGaD
Budesonide—Vision blurred—Doxorubicin—prostate cancer	9.73e-06	0.000147	CcSEcCtD
Budesonide—Asthenia—Docetaxel—prostate cancer	9.68e-06	0.000146	CcSEcCtD
Budesonide—Nausea—Etoposide—prostate cancer	9.65e-06	0.000145	CcSEcCtD
Budesonide—Hypertension—Epirubicin—prostate cancer	9.63e-06	0.000145	CcSEcCtD
Budesonide—Hypersensitivity—Capecitabine—prostate cancer	9.63e-06	0.000145	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	9.6e-06	0.00054	CbGpPWpGaD
Budesonide—Feeling abnormal—Prednisone—prostate cancer	9.59e-06	0.000145	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—prostate cancer	9.58e-06	0.000144	CcSEcCtD
Budesonide—Pruritus—Docetaxel—prostate cancer	9.55e-06	0.000144	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—prostate cancer	9.54e-06	0.000144	CcSEcCtD
Budesonide—Gastrointestinal pain—Prednisone—prostate cancer	9.52e-06	0.000143	CcSEcCtD
Budesonide—NR3C1—Gene Expression—DNMT3B—prostate cancer	9.51e-06	0.000535	CbGpPWpGaD
Budesonide—Arthralgia—Epirubicin—prostate cancer	9.5e-06	0.000143	CcSEcCtD
Budesonide—Myalgia—Epirubicin—prostate cancer	9.5e-06	0.000143	CcSEcCtD
Budesonide—Chest pain—Epirubicin—prostate cancer	9.5e-06	0.000143	CcSEcCtD
Budesonide—Agitation—Doxorubicin—prostate cancer	9.48e-06	0.000143	CcSEcCtD
Budesonide—Anxiety—Epirubicin—prostate cancer	9.46e-06	0.000143	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	9.43e-06	0.000142	CcSEcCtD
Budesonide—Discomfort—Epirubicin—prostate cancer	9.38e-06	0.000141	CcSEcCtD
Budesonide—Asthenia—Capecitabine—prostate cancer	9.38e-06	0.000141	CcSEcCtD
Budesonide—NR3C1—Gene Expression—RPL10—prostate cancer	9.33e-06	0.000525	CbGpPWpGaD
Budesonide—Malaise—Doxorubicin—prostate cancer	9.31e-06	0.00014	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—prostate cancer	9.29e-06	0.00014	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—prostate cancer	9.27e-06	0.00014	CcSEcCtD
Budesonide—Syncope—Doxorubicin—prostate cancer	9.26e-06	0.00014	CcSEcCtD
Budesonide—Urticaria—Prednisone—prostate cancer	9.25e-06	0.000139	CcSEcCtD
Budesonide—Pruritus—Capecitabine—prostate cancer	9.24e-06	0.000139	CcSEcCtD
Budesonide—Diarrhoea—Docetaxel—prostate cancer	9.23e-06	0.000139	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	9.22e-06	0.000519	CbGpPWpGaD
Budesonide—Abdominal pain—Prednisone—prostate cancer	9.2e-06	0.000139	CcSEcCtD
Budesonide—Body temperature increased—Prednisone—prostate cancer	9.2e-06	0.000139	CcSEcCtD
Budesonide—Confusional state—Epirubicin—prostate cancer	9.18e-06	0.000138	CcSEcCtD
Budesonide—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	9.15e-06	0.000515	CbGpPWpGaD
Budesonide—Palpitations—Doxorubicin—prostate cancer	9.12e-06	0.000137	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—prostate cancer	9.1e-06	0.000137	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	9.1e-06	0.000512	CbGpPWpGaD
Budesonide—Loss of consciousness—Doxorubicin—prostate cancer	9.07e-06	0.000137	CcSEcCtD
Budesonide—Infection—Epirubicin—prostate cancer	9.04e-06	0.000136	CcSEcCtD
Budesonide—Cough—Doxorubicin—prostate cancer	9.01e-06	0.000136	CcSEcCtD
Budesonide—Shock—Epirubicin—prostate cancer	8.96e-06	0.000135	CcSEcCtD
Budesonide—Diarrhoea—Capecitabine—prostate cancer	8.94e-06	0.000135	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GGT1—prostate cancer	8.93e-06	0.000503	CbGpPWpGaD
Budesonide—Nervous system disorder—Epirubicin—prostate cancer	8.93e-06	0.000135	CcSEcCtD
Budesonide—Dizziness—Docetaxel—prostate cancer	8.92e-06	0.000135	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—prostate cancer	8.91e-06	0.000134	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—prostate cancer	8.88e-06	0.000134	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—prostate cancer	8.84e-06	0.000133	CcSEcCtD
Budesonide—NR3C1—Gene Expression—HIST1H4H—prostate cancer	8.84e-06	0.000497	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NPPA—prostate cancer	8.84e-06	0.000497	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	8.82e-06	0.000496	CbGpPWpGaD
Budesonide—Hyperhidrosis—Epirubicin—prostate cancer	8.8e-06	0.000133	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—NCOA1—prostate cancer	8.8e-06	0.000495	CbGpPWpGaD
Budesonide—Arthralgia—Doxorubicin—prostate cancer	8.79e-06	0.000132	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—prostate cancer	8.79e-06	0.000132	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—prostate cancer	8.79e-06	0.000132	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—prostate cancer	8.76e-06	0.000132	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.73e-06	0.000132	CcSEcCtD
Budesonide—NR3C1—Gene Expression—MED12—prostate cancer	8.7e-06	0.000489	CbGpPWpGaD
Budesonide—Discomfort—Doxorubicin—prostate cancer	8.68e-06	0.000131	CcSEcCtD
Budesonide—Anorexia—Epirubicin—prostate cancer	8.68e-06	0.000131	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	8.67e-06	0.000488	CbGpPWpGaD
Budesonide—Dizziness—Capecitabine—prostate cancer	8.64e-06	0.00013	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—prostate cancer	8.59e-06	0.00013	CcSEcCtD
Budesonide—Vomiting—Docetaxel—prostate cancer	8.58e-06	0.000129	CcSEcCtD
Budesonide—Hypersensitivity—Prednisone—prostate cancer	8.58e-06	0.000129	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IL6—prostate cancer	8.56e-06	0.000482	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	8.55e-06	0.000481	CbGpPWpGaD
Budesonide—Hydrocortisone—CYP3A4—prostate cancer	8.55e-06	0.00491	CrCbGaD
Budesonide—Rash—Docetaxel—prostate cancer	8.51e-06	0.000128	CcSEcCtD
Budesonide—Dermatitis—Docetaxel—prostate cancer	8.5e-06	0.000128	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—prostate cancer	8.49e-06	0.000128	CcSEcCtD
Budesonide—Headache—Docetaxel—prostate cancer	8.45e-06	0.000127	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—prostate cancer	8.42e-06	0.000127	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—RXRA—prostate cancer	8.37e-06	0.000471	CbGpPWpGaD
Budesonide—Infection—Doxorubicin—prostate cancer	8.37e-06	0.000126	CcSEcCtD
Budesonide—Asthenia—Prednisone—prostate cancer	8.35e-06	0.000126	CcSEcCtD
Budesonide—Vomiting—Capecitabine—prostate cancer	8.31e-06	0.000125	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.29e-06	0.000125	CcSEcCtD
Budesonide—Shock—Doxorubicin—prostate cancer	8.29e-06	0.000125	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—prostate cancer	8.26e-06	0.000125	CcSEcCtD
Budesonide—Rash—Capecitabine—prostate cancer	8.24e-06	0.000124	CcSEcCtD
Budesonide—Pruritus—Prednisone—prostate cancer	8.23e-06	0.000124	CcSEcCtD
Budesonide—Insomnia—Epirubicin—prostate cancer	8.23e-06	0.000124	CcSEcCtD
Budesonide—Dermatitis—Capecitabine—prostate cancer	8.23e-06	0.000124	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—prostate cancer	8.22e-06	0.000124	CcSEcCtD
Budesonide—Headache—Capecitabine—prostate cancer	8.19e-06	0.000123	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—prostate cancer	8.18e-06	0.000123	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—prostate cancer	8.17e-06	0.000123	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—prostate cancer	8.14e-06	0.000123	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—prostate cancer	8.12e-06	0.000122	CcSEcCtD
Budesonide—Somnolence—Epirubicin—prostate cancer	8.09e-06	0.000122	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—COMT—prostate cancer	8.06e-06	0.000454	CbGpPWpGaD
Budesonide—Anorexia—Doxorubicin—prostate cancer	8.03e-06	0.000121	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTP1—prostate cancer	8.02e-06	0.000451	CbGpPWpGaD
Budesonide—Nausea—Docetaxel—prostate cancer	8.02e-06	0.000121	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—prostate cancer	8.01e-06	0.000121	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	7.99e-06	0.00045	CbGpPWpGaD
Budesonide—Diarrhoea—Prednisone—prostate cancer	7.96e-06	0.00012	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	7.95e-06	0.000447	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	7.91e-06	0.000445	CbGpPWpGaD
Budesonide—Decreased appetite—Epirubicin—prostate cancer	7.91e-06	0.000119	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—prostate cancer	7.86e-06	0.000118	CcSEcCtD
Budesonide—Fatigue—Epirubicin—prostate cancer	7.85e-06	0.000118	CcSEcCtD
Budesonide—Constipation—Epirubicin—prostate cancer	7.78e-06	0.000117	CcSEcCtD
Budesonide—Pain—Epirubicin—prostate cancer	7.78e-06	0.000117	CcSEcCtD
Budesonide—Nausea—Capecitabine—prostate cancer	7.76e-06	0.000117	CcSEcCtD
Budesonide—Dizziness—Prednisone—prostate cancer	7.7e-06	0.000116	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.67e-06	0.000116	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—prostate cancer	7.62e-06	0.000115	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—prostate cancer	7.56e-06	0.000114	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—prostate cancer	7.51e-06	0.000113	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—prostate cancer	7.5e-06	0.000113	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—prostate cancer	7.49e-06	0.000113	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—prostate cancer	7.44e-06	0.000112	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—prostate cancer	7.41e-06	0.000112	CcSEcCtD
Budesonide—Vomiting—Prednisone—prostate cancer	7.4e-06	0.000112	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	7.4e-06	0.000416	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS19—prostate cancer	7.4e-06	0.000416	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—prostate cancer	7.37e-06	0.000415	CbGpPWpGaD
Budesonide—Rash—Prednisone—prostate cancer	7.34e-06	0.000111	CcSEcCtD
Budesonide—Dermatitis—Prednisone—prostate cancer	7.33e-06	0.000111	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—prostate cancer	7.32e-06	0.00011	CcSEcCtD
Budesonide—Headache—Prednisone—prostate cancer	7.29e-06	0.00011	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	7.27e-06	0.000409	CbGpPWpGaD
Budesonide—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.27e-06	0.00011	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—prostate cancer	7.26e-06	0.000109	CcSEcCtD
Budesonide—Urticaria—Epirubicin—prostate cancer	7.23e-06	0.000109	CcSEcCtD
Budesonide—Pain—Doxorubicin—prostate cancer	7.2e-06	0.000109	CcSEcCtD
Budesonide—Constipation—Doxorubicin—prostate cancer	7.2e-06	0.000109	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—prostate cancer	7.2e-06	0.000108	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—prostate cancer	7.2e-06	0.000108	CcSEcCtD
Budesonide—NR3C1—Gene Expression—DNMT1—prostate cancer	7.07e-06	0.000398	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	7.01e-06	0.000394	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	6.99e-06	0.000393	CbGpPWpGaD
Budesonide—Feeling abnormal—Doxorubicin—prostate cancer	6.94e-06	0.000105	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NCOA2—prostate cancer	6.94e-06	0.00039	CbGpPWpGaD
Budesonide—Nausea—Prednisone—prostate cancer	6.91e-06	0.000104	CcSEcCtD
Budesonide—CYP3A4—Metabolism—HAO1—prostate cancer	6.9e-06	0.000388	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	6.89e-06	0.000388	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Doxorubicin—prostate cancer	6.89e-06	0.000104	CcSEcCtD
Budesonide—NR3C1—Gene Expression—EZH2—prostate cancer	6.85e-06	0.000385	CbGpPWpGaD
Budesonide—Hypersensitivity—Epirubicin—prostate cancer	6.71e-06	0.000101	CcSEcCtD
Budesonide—NR3C1—Gene Expression—PARP1—prostate cancer	6.7e-06	0.000377	CbGpPWpGaD
Budesonide—Urticaria—Doxorubicin—prostate cancer	6.69e-06	0.000101	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—prostate cancer	6.66e-06	0.0001	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—prostate cancer	6.66e-06	0.0001	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	6.57e-06	0.00037	CbGpPWpGaD
Budesonide—Asthenia—Epirubicin—prostate cancer	6.53e-06	9.85e-05	CcSEcCtD
Budesonide—Pruritus—Epirubicin—prostate cancer	6.44e-06	9.71e-05	CcSEcCtD
Budesonide—Dexamethasone—CYP3A4—prostate cancer	6.37e-06	0.00366	CrCbGaD
Budesonide—NR3C1—Gene Expression—HSPA1A—prostate cancer	6.35e-06	0.000357	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR2—prostate cancer	6.35e-06	0.000357	CbGpPWpGaD
Budesonide—Dexamethasone—PTGS2—prostate cancer	6.24e-06	0.00358	CrCbGaD
Budesonide—Diarrhoea—Epirubicin—prostate cancer	6.23e-06	9.39e-05	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—prostate cancer	6.21e-06	9.36e-05	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—prostate cancer	6.04e-06	9.11e-05	CcSEcCtD
Budesonide—Dizziness—Epirubicin—prostate cancer	6.02e-06	9.08e-05	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—prostate cancer	5.96e-06	8.98e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NCOA1—prostate cancer	5.85e-06	0.000329	CbGpPWpGaD
Budesonide—Vomiting—Epirubicin—prostate cancer	5.79e-06	8.73e-05	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—prostate cancer	5.76e-06	8.69e-05	CcSEcCtD
Budesonide—Rash—Epirubicin—prostate cancer	5.74e-06	8.65e-05	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—prostate cancer	5.73e-06	8.65e-05	CcSEcCtD
Budesonide—Headache—Epirubicin—prostate cancer	5.7e-06	8.6e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—ADI1—prostate cancer	5.62e-06	0.000316	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PSAT1—prostate cancer	5.62e-06	0.000316	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GRHL1—prostate cancer	5.62e-06	0.000316	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CSAD—prostate cancer	5.62e-06	0.000316	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CBR1—prostate cancer	5.62e-06	0.000316	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TST—prostate cancer	5.62e-06	0.000316	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AR—prostate cancer	5.61e-06	0.000315	CbGpPWpGaD
Budesonide—Dizziness—Doxorubicin—prostate cancer	5.57e-06	8.4e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—RXRA—prostate cancer	5.56e-06	0.000313	CbGpPWpGaD
Budesonide—Nausea—Epirubicin—prostate cancer	5.41e-06	8.15e-05	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—prostate cancer	5.36e-06	8.07e-05	CcSEcCtD
Budesonide—Rash—Doxorubicin—prostate cancer	5.31e-06	8.01e-05	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—prostate cancer	5.31e-06	8e-05	CcSEcCtD
Budesonide—Headache—Doxorubicin—prostate cancer	5.28e-06	7.96e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—CKMT2—prostate cancer	5.23e-06	0.000294	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GRHPR—prostate cancer	5.23e-06	0.000294	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UGT2B15—prostate cancer	5.23e-06	0.000294	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UGT2B17—prostate cancer	5.23e-06	0.000294	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SIRT1—prostate cancer	5.11e-06	0.000287	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—VDR—prostate cancer	5.04e-06	0.000283	CbGpPWpGaD
Budesonide—Nausea—Doxorubicin—prostate cancer	5e-06	7.54e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—AOX1—prostate cancer	4.92e-06	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAGLU—prostate cancer	4.92e-06	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PGAM2—prostate cancer	4.92e-06	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.92e-06	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—RFK—prostate cancer	4.92e-06	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.92e-06	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM3—prostate cancer	4.92e-06	0.000277	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AMACR—prostate cancer	4.66e-06	0.000262	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP3A43—prostate cancer	4.66e-06	0.000262	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SRD5A2—prostate cancer	4.66e-06	0.000262	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAT1—prostate cancer	4.66e-06	0.000262	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DEGS1—prostate cancer	4.66e-06	0.000262	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ERCC2—prostate cancer	4.61e-06	0.000259	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.45e-06	0.00025	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARA—prostate cancer	4.25e-06	0.000239	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	4.16e-06	0.000234	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.96e-06	0.000223	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HPGD—prostate cancer	3.96e-06	0.000223	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR1—prostate cancer	3.85e-06	0.000217	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.73e-06	0.00021	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTAP—prostate cancer	3.62e-06	0.000204	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.62e-06	0.000204	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.53e-06	0.000199	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.53e-06	0.000199	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CREBBP—prostate cancer	3.37e-06	0.00019	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACSL4—prostate cancer	3.37e-06	0.00019	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.37e-06	0.00019	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UMPS—prostate cancer	3.23e-06	0.000182	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PHGDH—prostate cancer	3.23e-06	0.000182	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ARG2—prostate cancer	3.23e-06	0.000182	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LDHB—prostate cancer	3.17e-06	0.000178	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—prostate cancer	3.16e-06	0.000178	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.11e-06	0.000175	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PDHA1—prostate cancer	3e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA3—prostate cancer	3e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UCP3—prostate cancer	3e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TCN2—prostate cancer	3e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.86e-06	0.000161	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.86e-06	0.000161	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA4—prostate cancer	2.75e-06	0.000154	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.75e-06	0.000154	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA2—prostate cancer	2.68e-06	0.000151	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.64e-06	0.000149	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG5—prostate cancer	2.64e-06	0.000149	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA1—prostate cancer	2.58e-06	0.000145	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTO1—prostate cancer	2.55e-06	0.000144	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.55e-06	0.000144	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAT2—prostate cancer	2.55e-06	0.000144	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLCB2—prostate cancer	2.45e-06	0.000138	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LRP2—prostate cancer	2.45e-06	0.000138	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.45e-06	0.000138	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—P4HB—prostate cancer	2.4e-06	0.000135	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.34e-06	0.000131	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.28e-06	0.000128	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MED12—prostate cancer	2.24e-06	0.000126	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNG5—prostate cancer	2.22e-06	0.000125	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA3—prostate cancer	2.14e-06	0.00012	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HPGDS—prostate cancer	2.04e-06	0.000115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.03e-06	0.000114	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—prostate cancer	2e-06	0.000113	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACHE—prostate cancer	1.98e-06	0.000111	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTT1—prostate cancer	1.98e-06	0.000111	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.96e-06	0.00011	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.9e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PRKACB—prostate cancer	1.89e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.87e-06	0.000105	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA2—prostate cancer	1.79e-06	0.0001	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.7e-06	9.58e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.66e-06	9.36e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NQO1—prostate cancer	1.65e-06	9.26e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TH—prostate cancer	1.62e-06	9.12e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.58e-06	8.87e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GGT1—prostate cancer	1.53e-06	8.59e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA1—prostate cancer	1.5e-06	8.47e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.48e-06	8.34e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—RXRA—prostate cancer	1.43e-06	8.05e-05	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—prostate cancer	1.39e-06	7.81e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COMT—prostate cancer	1.38e-06	7.76e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTP1—prostate cancer	1.37e-06	7.72e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ITPR1—prostate cancer	1.35e-06	7.6e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TYMS—prostate cancer	1.28e-06	7.18e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—prostate cancer	1.26e-06	7.09e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPL—prostate cancer	1.24e-06	6.96e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.2e-06	6.72e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ERCC2—prostate cancer	1.19e-06	6.67e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—prostate cancer	1.11e-06	6.27e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARA—prostate cancer	1.09e-06	6.15e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAV1—prostate cancer	1.03e-06	5.78e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.36e-07	5.27e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—INS—prostate cancer	8.86e-07	4.99e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CREBBP—prostate cancer	8.68e-07	4.88e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.23e-07	4.63e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NOS3—prostate cancer	7.77e-07	4.37e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.17e-07	4.04e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—prostate cancer	7.11e-07	4e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTEN—prostate cancer	6.2e-07	3.49e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—EP300—prostate cancer	5.91e-07	3.33e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.37e-07	2.46e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—prostate cancer	3.57e-07	2.01e-05	CbGpPWpGaD
